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Abstract 
4”-O-(4-methoxyphenyl)acetyltyosin (YM133) is an acyl derivative of tylosin (TS), and shows results of 
antibacterial activity against macrolide-lincosamide-streptogramin type B (MLSB) constitutive resistant Staph-
ylococcus aureus.  The minimum inhibitory concentrations (MICs) for MLSB constitutive resistant strain 
ISP217 were 12.5μg/ml for YM133 and puromycin (PM), whereas the MICs were more than 800μg/ml for 
erythromycin (EM), josamycin (JM), TS, lincomycin (LCM), and mikamycin type B. The MICs for PM were 
12.5μg/ml for MLSB sensitive strain NCTC8325, MLSB inducible resistant strain ISP447, and MLSB constitutive 
resistant strain ISP217.  The 50% growth inhibition doses (ID50) of YM133 and TS against MLSB sensitive 
strain and MLSB inducible resistant stain were both approximately 0.12μg/ml, indicating that these antibiotics 
have the same effect towards these strains. The ID50 of YM133 against MLSB constitutive resistant strain was 
29.9μg/ml, which was approximately 36 times larger in its effect compared to TS.  The results from the Drug-
probit relationship showed that the degrees of the slopes concerning YM133 against ISP217 and PM against 
ISP217 were identical, suggesting YM133 and PM having the same action mechanism against strain ISP217. 
The slopes concerning TS against NCTC8325 and TS against ISP217 share almost identical degrees in their 
slopes, indicating that the action mechanisms for TS against those two strains are the same. 
1. Introduction
It is commonly known that multiple drug resistant
bacteria are reproduced as a result of overuse and/or 
repeated use of antibiotics. Clinically isolated S. au-
reus resistance strains are one example of multiple 
drug resistant bacteria and are found to exhibit in-
ducible-resistance and constitutive- resistance to not 
only macrolide (Mac) antibiotics, but also to lincosa-
mide and streptogramin type B antibiotic (MLSB) 
(1,2,3,4). Therefore, it should be considered as a so-
cial priority to rationally develop effective anti-  
microbial drugs which could overcome the resistant 
mechanism of bacteria, as well as search for new 
antibiotics. 
Since 1968, Nakajima et al. have been contrib-
uting to the research of macrolide’s mode of action 
and drug resistance mechanism using Mac resistant 
S. aureus, for the purpose of improving the effective-
ness of Mac antibiotics. In recent years, several new 
semisynthetic derivatives of Mac have been devel-
oped by chemical modification and it has been re-
ported to be effective against MLSB resistance S. au-
reus in both clinical treatments and in vitro.  In 1987, 
Takeuchi et al.(5) reported the findings which showed 
that the various derivatives of tylosin (TS) in 16-
membered ring Mac had an antibacterial activity 
against MLSB resistance S. aureus. 
The present study aimed to examine the proper-
ties of action mechanism of YM133, that is, the de-
rivatives of TS. The following S. aureus were used: 
Mac susceptibility strain, MLSB inducible resistance 
strain, and MLSB constitutive resistance strain. The 
current study also aimed to describe the new anti-
microbial activity against MLSB constitutive re-
sistance strain, by addressing the findings of the 
MICs of YM133, and the effect of YM133 on the 
growth of MLSB constitutive resistance S. aureus. 
2. Materials and Methods
2.1 Strain 
   S. aureus NCTC8325 was used as a Mac sensi-
tive strain. MLSB inducible-resistant S. aureus 
ISP447 and MLSB constitutive-resistant S. aureus 
ISP217 kindly donated by Dr. P. A. Pattee, were also 
used (1,6). 
2.2 Media and reagents 
   As media for MIC measurements, trypticase soy 
broth (TSB) and Muller Hinton Ⅱ Agar (MH Ⅱ) ob-
tained from Beckton Dickinson Company (BBL) were 
used. As media for resistance induction ability 
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 measurements, the following media were used; 
Heart Infusion Agar (HIA) obtained from BBL; Induc-
ible Base (Ind. B) agar medium containing poly- 
peptone 5 g, yeast extract 5 g, monopotassium phos-
phate 1 g, glucose 2 g, and agar 20 g per 1 L of pu-
rified water; and Inducible Soft (Ind. S) agar medium 
which had the same composition to Ind. B except 
that 5 g of agar was used instead of 20 g (7). For drug 
susceptibility measurements by liquid culture 
method, TSB and medium H (pH 7.6) containing 
pancreatic digest of gelatin 5 g, beef extract 3 g, 
yeast extract 2 g, and HEPES 11.8 g per 1 l of puri-
fied water, were used (8). The reagent of HEPES (N-
2-hydroxyethyl-piperazine-N’-2-ethane sulfonic acid) 
from Nacalai Tesque Ltd. was used. All other rea-
gents were purchased. 
2.3 Antibiotics 
   Antibiotics used in this study were; erythromycin 
(EM) and lincomycin (LCM) obtained from Japan 
Upjohn; tylosin (TS) and puromycin (PM) obtained 
from SIGMA; josamycin (JM) from Meiji Seika Ltd.; 
4”-O-(4-methoxyphenyl) acetyltylosin (YM133) ob-
tained from Mercian Central Institute Ltd.; and mika-
mycin-B (MKM-B) was purified from a mikamycin 
mixture (obtained from Banyu Pharmaceutical Ltd.) 
using the HPLC method. 
2.4 Minimum Inhibitory Concentrations (MICs) 
   Determination of MICs was achieved by a serial 
two-hold dilution of antibiotics in MH Ⅱ agar. Each 
plate containing the drug was seeded by Micro Inoc-
ulater (MI type 1; Sakuma factory) with an inoculum 
size of about 104 cfu/ml of overnight-cultured strains. 
The MIC was defined as being the lowest concentra-
tion of drug that would inhibit visible growth after in-
cubation at 37℃ for 18 to 24 hr (9). 
2.5 Effect of resistance induction of erythromy-
cin 
   The inducibility of resistance to Mac antibiotics by 
EM was assayed by the agar disc diffusion test: Ind. 
S (8 ml) including bacteria (106 cells) was poured 
onto the previous Ind. B (40 ml). After the Ind. S layer 
was hardened, several paper discs of 8 mm in diam-
eter with antibiotics were separately placed on the 
agar surface. The plates were then incubated at 37℃ 
for 18 to 24 hours (7,9,10,11). 
2.6 Growth inhibition   An overnight culture of S. 
aureus in BHI broth was diluted 1:9 with a fresh cul-
ture medium H (pH 7.6). After 2-hour incubation at 
37℃, the culture was further diluted to an optical 
density (OD) of about 0.1 at 610 nm in an L-shaped 
tube (L-tube) containing medium H plus antibiotic, 
(total volume of 10 ml) incubated at 37℃ for one 
hour with shaking, and chilled rapidly to 0℃. The 
chilled cells were harvested by centrifugation (Hita-
chi, HIMAC Centrifuge CR5B), at 4,000×g for 10 
minutes at 4℃ and washed twice with two 5-ml por-
tions of cold 0.9% NaCl solution. The washed cells 
were suspended in 10 ml of antibiotic- free medium 
H, and adjusted to an OD of about 0.1 at 610 nm. 
The cell suspension in an L- tube was further incu-
bated at 37℃ with shaking, and the growth of the 
suspension was determined by monitoring OD at 610 
nm (12). 
The 50% inhibitory dose (ID50) was determined as 
follows: overnight cultures of S. aureus were added 
to a fresh medium H and incubated to log phase. Af-
ter cells were collected by centrifugation and were 
suspended in fresh medium H, mixed with a serial 
two-third dilution of antibiotics, and incubated at 37℃ 
with gentle shaking. The ID50 of antibiotics was de-
termined by probit analysis (13). 
 
3. Results 
3.1 Antimicrobial susceptibility of Staphylococ-
cus aureus 
   The MICs for a susceptible strain NCTC8325 and 
MLSB inducible resistant strain ISP447 (prior to re-
sistance induction) were 6.25μg/ml or less for EM, 
JM, TS, YM133, LCM and MKM-B (Table 1). The 
MICs for MLSB constitutive resistant strain ISP217 
were more than 800μg/ml for all antibiotics tested, 
except for YM133 and PM (12.5μg/ml, 12.5μg/ml re-
spectively) (Table 1). Moreover, the MICs for PM 





3.2 The effect of resistance induction with eryth-
romycin 
   As EM diffused into agar medium, strain ISP447 
formed ‘D-shaped’ inhibition zones due to the induc-
tion of resistance to JM, YM133, and TS (Fig. 1). In 
contrast, for strain ISP217, no zone was formed due 
to the induction of resistance to JM and TS, whereas 




3.3 The effects of YM133, tylosin, and puromycin 
on the growth of Staphylococcus aureus NCTC 
8325 
   Figure 2 (A) shows that the growth rate of NCTC 
8325 did not differ between control (0.0μg/ml) and 
0.23μg/ml of YM133 up to two hours. After two hours, 
OD stopped rising at the point of 0.5, showing inhibi-
tion of growth for YM133 concentration of 0.23μg/ml. 
In contrast, when TS was used, the growth inhibition 
occurred in proportion to its concentration (Fig. 2B). 
When PM was used with a concentration of 
2.70μg/ml, the growth inhibition curb resembled the 
curb for YM133 with the concentration of 0.23μg/ml, 
showing growth inhibition after 2 hours (Fig. 2C).  
3.4 The concentration-probit relationship and 
50% growth inhibitory doses (ID50) of antibiotics 
against Staphylococcus aureus. 
The concentration-probit (10) relationship was an-





The relationship shows that the degrees of the slope 
for YM133 against strain ISP217, PM against strain 
ISP217, and PM against NCTC8325 were identical 
(Fig. 3). The results also show that the degrees of 
the slopes for TS against strain ISP217 and TS 
against NCTC8325 were almost identical (Fig. 3). 
The degree of the slope was found to be sharper for 
YM133 against NCTC8325 compared to other 




To compare susceptibility of YM133, TS, and PM 
quantitatively, 50% growth inhibitory doses were cal-
culated by liquid culture method. The ID50 values of 
YM133 and TS did not show a great difference be-
tween strain NCTC8325 and ISP447 (ranging from 
0.12 to 0.13μg/ml). In contrast, the ID50 values of 
YM133 and TS for ISP217 were 0.82μg/ml and 
29.9μg/ml respectively (Table 2). The ID50 values of 
YM133 and TS showed that these antibiotics had the 
same effects to MLSB sensitive-, resistant strain and 
MLSB inducible-resistant strain, whereas YM133 had 
the effect to MLSB resistant strain which was an ap-
proximately 36 times larger effect to MLSB-





Mac is known to be bound to ribosome 50S sub-
unit, bringing along the change in conformation of 
ribosome. As a result of this, protein synthesis is in-
hibited. From the process of cell-free protein syn-
thesis and its inhibitory mechanism, it can be said 
that the translocation of peptidyl-transfer RNA and 
peptidyltransferase are inhibited (14,15,16,17). In con-
trast, the resistance mechanism of MLSB inducible 
resistant strain ISP447 and MLSB constitutive re-
sistant strain IPS217 produce ribosome methylase. 
As a result of this, the mechanism that is due to N6, 
N6-dimethylation of a specific adenine residue in 
23S ribosomal RNA, renders ribosomes unable to 
bind to EM, as the resistance was due to alteration 
of ribosome (4,18,19). 
However, the current research indicated that un-
like new and old Mac, YM133 showed an antimicro-
bial activity in not only MLSB-sensitive S. aureus 
NCTC8325 but also in Mac constitutive MLSB-
resistant S. aureus ISP217. Being consistent with 
the findings of Takeuchi et al. (5) and Terasawa et al. 
(20), the MICs for both YM133 and PM against 
ISP217 strain were 12.5 mg/ml (Table 1), indicating 
susceptibility. Furthermore, in examining the induc-
tion of resistance using EM against inducible MLSB-
resistant S. aureus ISP447, YM133 formed ‘D-
shaped’ growth inhibitory zone, showing the same 
effect to the already-known Mac (Fig. 1). On the 
other hand, a completely different effect to the al-
ready-known Mac was found for the experiment us-
ing S. aureus ISP217, illustrating that YM133 
formed ‘round-shaped’ growth inhibitory zone with a 
presence of EM, instead of ‘D-shaped’. The results  
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 strongly suggest that YM133 has a resistance 
against the resistance mechanism of Mac which oc-
curred as a result of dimethylation of ribosomes. 
In the experiment of the effects of YM133 against 
the growth of S. aureus NCTC8325, the growth in-
hibition was only observed after 2 hours and forward. 
Generally, it is known that Mac has the ability to in-
hibit the growth of bacteria in proportion to its drug 
concentration. The authors noticed, by observing 
YM133 inhibiting the growth of MLSB constitutive re-
sistant strain ISP217, that YM133 and PM had great 
similarity in their chemical structures, both having 
methoxyphenyl (Fig. 4). 
The results from Drug-Probit relationship illus-
trated that the degrees of the slopes concerning 
YM133 against strain ISP217 and PM against strain 
ISP217 were identical (Fig. 3). Therefore, it can be 
suggested that YM133 and PM have the same ac-
tion mechanism against strain ISP217 (Fig. 3). 
Moreover, TS against strain ISP217 and TS against 
strain NCTC8325 share almost identical degrees in 
their slopes, indicating that the action mechanisms 
for TS against those two strains are the same (Fig. 
3). The finding also suggests that the effect of 
YM133 against strain NCTC8325 is the additive ac-
tion of TS and PM. 
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